A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Qu\'ebec Administrative Data
Cong Jiang, Denis Talbot, Sara Carazo, Mireille E Schnitzer

TL;DR
This paper introduces a novel double machine learning estimator, TNDDR, for evaluating COVID-19 vaccine effectiveness using test-negative design data, enhancing confounder adjustment with theoretical and empirical support.
Contribution
It proposes a new doubly robust, locally efficient estimator that incorporates machine learning for better confounder control in COVID-19 VE assessment under TND.
Findings
The TNDDR estimator achieves $\
The estimator is both theoretically justified and empirically validated.
It improves confounder adjustment in vaccine effectiveness studies.
Abstract
The test-negative design (TND), which is routinely used for monitoring seasonal flu vaccine effectiveness (VE), has recently become integral to COVID-19 vaccine surveillance, notably in Qu\'ebec, Canada. Some studies have addressed the identifiability and estimation of causal parameters under the TND, but efficiency bounds for nonparametric estimators of the target parameter under the unconfoundedness assumption have not yet been investigated. Motivated by the goal of improving adjustment for measured confounders when estimating COVID-19 VE among community-dwelling people aged years in Qu\'ebec, we propose a one-step doubly robust and locally efficient estimator called TNDDR (TND doubly robust), which utilizes cross-fitting (sample splitting) and can incorporate machine learning techniques to estimate the nuisance functions and thus improve control for measured confounders. We…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Influenza Virus Research Studies
